Study on Neurotoxic effects of Digoxin different doses in mice
The present study was designed to evaluate neurobehavioral effects of two doses of digoxin( therapeutic and double dose) in mice.Two treatment groups( T1, T2), each consist of 10 mice divided according to daily oral treatment with Digoxin representing dosing orally with 5 ,10microgram/kg respect...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Veterinary Medicine, University of Kufa
2017-12-01
|
| Series: | Kufa Journal for Veterinary Medical Sciences |
| Subjects: | |
| Online Access: | https://journal.uokufa.edu.iq/index.php/kjvs/article/view/4108 |
| Summary: | The present study was designed to evaluate neurobehavioral effects of two doses of digoxin( therapeutic and double dose) in mice.Two treatment groups( T1, T2), each consist of 10 mice divided according to daily oral treatment with Digoxin representing dosing orally with 5 ,10microgram/kg respectively the third group considered as control and treated with distilled water.
Neurobehavioral results showed that digioxin in T2 caused significant decrease proportional with the dose in autonomic and central nervous system activity manifested by in decrease urination frequency and fecal boluses, disturbance of vestibular system ,increase of time needed for 180° turning upward to avoid slope, and defect in degree of cognitive function of exploration , and neuromuscular compatibility with disturbance of locomotor activity( proportional with dose and period of exposure) .
While T1 showed significant effect in disturbance of vestibular system ,increase of time needed for 180° turning upward to avoid slope,and righting reflex , and neuromuscular compatibility with disturbance of locomotor activity( proportional with dose and period of exposure) ,while there were no significant change in other parameters above at that period.
In conclusion this study revealed that digoxin of both dose 5mcg/kg and10 mcg/kg in caused abnormal neurobehaviord effect propotinal with the dose and period of expouser even at the therapeutic dose that indicate the precaution in using such drug.
|
|---|---|
| ISSN: | 2077-9798 2959-8478 |